Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
45.11
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Total Liabilities (Quarterly) : 396.88M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 396.88M |
| March 31, 2026 | 423.92M |
| December 31, 2025 | 552.44M |
| September 30, 2025 | 370.09M |
| June 30, 2025 | 318.50M |
| March 31, 2025 | 316.58M |
| December 31, 2024 | 465.07M |
| September 30, 2024 | 335.55M |
| June 30, 2024 | 358.38M |
| March 31, 2024 | 374.92M |
| December 31, 2023 | 487.46M |
| September 30, 2023 | 372.97M |
| June 30, 2023 | 373.19M |
| March 31, 2023 | 879.66M |
| December 31, 2022 | 951.18M |
| September 30, 2022 | 840.33M |
| June 30, 2022 | 853.54M |
| March 31, 2022 | 811.07M |
| December 31, 2021 | 1.018B |
| September 30, 2021 | 744.57M |
| June 30, 2021 | 787.48M |
| March 31, 2021 | 753.00M |
| December 31, 2020 | 842.10M |
| September 30, 2020 | 801.14M |
| June 30, 2020 | 825.05M |
| Date | Value |
|---|---|
| March 31, 2020 | 576.48M |
| December 31, 2019 | 602.14M |
| September 30, 2019 | 549.65M |
| June 30, 2019 | 540.77M |
| March 31, 2019 | 545.43M |
| December 31, 2018 | 556.25M |
| September 30, 2018 | 500.58M |
| June 30, 2018 | 462.31M |
| March 31, 2018 | 473.29M |
| December 31, 2017 | 171.95M |
| September 30, 2017 | 133.82M |
| June 30, 2017 | 116.97M |
| March 31, 2017 | 116.19M |
| December 31, 2016 | 117.81M |
| September 30, 2016 | 111.74M |
| June 30, 2016 | 108.41M |
| March 31, 2016 | 97.36M |
| December 31, 2015 | 100.62M |
| September 30, 2015 | 57.33M |
| June 30, 2015 | 82.19M |
| March 31, 2015 | 75.65M |
| December 31, 2014 | 66.15M |
| September 30, 2014 | 60.21M |
| June 30, 2014 | 60.82M |
| March 31, 2014 | 68.51M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 1.441B |
| Pfizer Inc. | 115.64B |
| Amphastar Pharmaceuticals, Inc. | 975.61M |
| Collegium Pharmaceutical, Inc. | 1.824B |
| Bristol Myers Squibb Co. | 65.32B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.428B |
| Shareholders Equity (Quarterly) | 1.031B |
| Debt to Equity Ratio | 0.039 |
| Current Ratio | 2.083 |
| Net Debt Paydown Yield | -0.06% |